Literature DB >> 3206086

Failure to thrive, wasting syndrome, and immunodeficiency in rabies: a hypophyseal/hypothalamic/thymic axis effect of rabies virus.

M J Torres-Anjel1, D Volz, M J Torres, M Turk, J G Tshikuka.   

Abstract

Studies of rabies virus in several animal models consistently showed hypothalamic infection, hypophyseal infection, dramatic growth impairment (in the form of failure to thrive), wasting syndrome, and immune depletion. Rabies virus infection was studied through routine monoclonal antinucleocapsid antibody immunofluorescence and through a peroxidase-antiperoxidase immunoperoxidase method. The latter was modified to detect the in situ production of growth hormone by uninfected and rabies virus-infected adeno-a-pituicytes (with confirmation of the results both in vivo and in vitro). Infection with rabies virus made the specialized pituicytes produce less growth hormone. Growth before rabies virus infection and its reduction due to infection were investigated in a linear regression model. The fit was statistically significant (P less than .05) in all species studied: mouse, rat, rabbit, cow, and cat. Immune depression was studied in terms of alterations in the immunotopography of the thymus and also the specific T- and B-cell homing areas of the spleen (although spleen data are not presented here). On the basis of these results and a thorough review of wasting syndromes encountered in other diseases, a primary failure to thrive and an ensuing wasting syndrome were described and characterized for rabies, and their origin was assigned to a dysfunction of the hypophyseal/hypothalamic/thymic axis associated with at least (but not necessarily only) one of the centrally controlled growth hormones.

Entities:  

Mesh:

Year:  1988        PMID: 3206086     DOI: 10.1093/clinids/10.supplement_4.s710

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

1.  Correlation of inducible nitric oxide synthase (iNOS) inhibition with TNF-α, caspase-1, FasL and TLR-3 in pathogenesis of rabies in mouse model.

Authors:  B P Madhu; K P Singh; M Saminathan; R Singh; A K Tiwari; V Manjunatha; C Harish; G B Manjunathareddy
Journal:  Virus Genes       Date:  2015-12-21       Impact factor: 2.332

2.  The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Authors:  Damien Chopy; Claudia N Detje; Mireille Lafage; Ulrich Kalinke; Monique Lafon
Journal:  J Neurovirol       Date:  2011-07-30       Impact factor: 2.643

3.  Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.

Authors:  S Van Gucht; R Beyaert; E Kip; J Staal; H G Tima; L Verstrepen; M Romano; K Lemeire; V Suin; A Hamouda; M Baens; C Libert; M Kalai
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

4.  Ambivalent role of the innate immune response in rabies virus pathogenesis.

Authors:  Damien Chopy; Julien Pothlichet; Mireille Lafage; Françoise Mégret; Laurence Fiette; Mustapha Si-Tahar; Monique Lafon
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

5.  Alteration of interleukin-1 alpha production and interleukin-1 alpha binding sites in mouse brain during rabies infection.

Authors:  C Marquette; P E Ceccaldi; E Ban; P Weber; H Tsiang; F Haour
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.

Authors:  Anirban Roy; D Craig Hooper
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

7.  Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs.

Authors:  Clement W Gnanadurai; Yang Yang; Ying Huang; Zhenguang Li; Christina M Leyson; Tanya L Cooper; Simon R Platt; Stephen B Harvey; Douglas C Hooper; Milosz Faber; Zhen F Fu
Journal:  PLoS Negl Trop Dis       Date:  2015-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.